Inflammatory, procoagulant markers and HIV residual viremia in patients receiving protease inhibitor monotherapy or triple drug therapy: a cross-sectional study

Miriam Estébanez, Natalia Stella-Ascariz, Jesús Mingorance, Ignacio Pérez-Valero, Jose Ignacio Bernardino, Francisco Xavier Zamora, Maria Luisa Montes, Juan Julián González-García, José Ramón Arribas

Open source

DOI
10.1186/1471-2334-14-379
Published
2014-07-10
Container
BMC Infectious Diseases
Publisher
Springer Science and Business Media LLC
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1186/1471-2334-14-379,
  title = {Inflammatory, procoagulant markers and HIV residual viremia in patients receiving protease inhibitor monotherapy or triple drug therapy: a cross-sectional study},
  author = {Miriam Estébanez and Natalia Stella-Ascariz and Jesús Mingorance and Ignacio Pérez-Valero and Jose Ignacio Bernardino and Francisco Xavier Zamora and Maria Luisa Montes and Juan Julián González-García and José Ramón Arribas},
  year = {2014},
  journal = {BMC Infectious Diseases},
  doi = {10.1186/1471-2334-14-379},
  url = {https://doi.org/10.1186/1471-2334-14-379}
}

RIS

TY  - JOUR
TI  - Inflammatory, procoagulant markers and HIV residual viremia in patients receiving protease inhibitor monotherapy or triple drug therapy: a cross-sectional study
AU  - Miriam Estébanez
AU  - Natalia Stella-Ascariz
AU  - Jesús Mingorance
AU  - Ignacio Pérez-Valero
AU  - Jose Ignacio Bernardino
AU  - Francisco Xavier Zamora
AU  - Maria Luisa Montes
AU  - Juan Julián González-García
AU  - José Ramón Arribas
PY  - 2014
JO  - BMC Infectious Diseases
DO  - 10.1186/1471-2334-14-379
UR  - https://doi.org/10.1186/1471-2334-14-379
ER  - 

APA

Estébanez, M., Stella-Ascariz, N., Mingorance, J., Pérez-Valero, I., Bernardino, J. I., Zamora, F. X., Montes, M. L., González-García, J. J., & Arribas, J. R. (2014). Inflammatory, procoagulant markers and HIV residual viremia in patients receiving protease inhibitor monotherapy or triple drug therapy: a cross-sectional study. BMC Infectious Diseases. https://doi.org/10.1186/1471-2334-14-379

Source records